The interventional neurology devices and equipment market has seen considerable growth due to a variety of factors.
• The market size for interventional neurology devices and equipment has seen robust growth in recent times. The market is projected to rise from a value of $2.33 billion in 2024 to an estimated $2.54 billion in 2025, displaying a compound annual growth rate (CAGR) of 8.7%.
The growth during the historical period can be credited to factors like high prevalence of cardiovascular disease, an aging demographic, patient preference for minimally invasive procedures, established clinical guidelines, and ongoing research.
The interventional neurology devices and equipment market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for significant growth in the interventional neurology devices and equipment market size in the coming years. It is projected to reach $3.61 billion in 2029, growing at a compound annual growth rate (CAGR) of 9.2%.
This anticipated growth during the forecast period can be credited to factors such as personalized medicine, telehealth integration, universal healthcare access, and robotic-assisted procedures. Other key trends predicted for the forecast period include the implementation of advanced imaging technologies, the use of artificial intelligence (AI) within interventional cardiology, treatment of complex lesions, and the introduction of next-generation drug-eluting stents (DES).
The anticipated surge in the Interventional neurology devices market is likely due to the escalating occurrence of neurological conditions. The incidences of neural disorders such as Alzheimer's disease, cerebrovascular diseases like stroke, migraine, and other headache disorders are multiplying. The swift growth of the elderly population, high levels of stress in younger people, and head injuries from accidents contribute significantly to neural conditions. For example, based on data from the Brain Aneurysm Foundation, a US-based establishment for brain aneurysm knowledge and education, approximately 6 million people in the United States suffer from non-ruptured brain aneurysms. Additionally, information from the World Health Organization, a US-based health entity, states that globally, over 50 million individuals have epilepsy, and more than 47 million are dealing with dementia. Hence, the escalating occurrence of neurological afflictions is set to bolster the growth of the Interventional neurology devices market in the future.
The interventional neurology devices and equipment market covered in this report is segmented –
1) By Type: Aneurysm Coiling And Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices, Support Devices
2) Aneurysm Coiling And Embolization Devices By Type: Embolic coils, Flow diversion devices, Liquid embolic devices
3) Angioplasty Devices by Type: Carotid artery stents, Embolic protection systems
4) Support Devices By Type, Micro guide wires, Micro catheters
5) Neurothrombectomy Devices By Type: CLOT retrieval devices, Suction and aspiration devices, Snare
6) By End-User: Hospitals, Neurology clinics, Ambulatory care centers and others
Subsegments:
1) By Aneurysm Coiling And Embolization Devices: Flow Diverters, Embolic Coils, Liquid Embolics
2) By Cerebrospinal Fluid (CSF) Management Devices: CSF Shunts, CSF Drainage Systems
3) By Neurothrombectomy Devices: Clot Retrievers, Aspiration Devices, Snares
4) By Support Devices: Microcatheters, Guidewires
The most recent innovation from Stryker Inc., the Neuroform Atlas Stent System, is poised to deliver substantial outcomes in the treatment of brain aneurysms via embolic coils. Such advancements have the potential to propel the interventional neurological device market forward. The Atlas stent system lends robust support to coiling procedures, and is engineered to offer the coil support and wall apposition required for effective stent-assisted coilage. With its improved stent conformability, slimline delivery system and precise deployment even in complex anatomy, the Neuroform Atlas is fast becoming the preferred choice for neurosurgeons, thereby influencing the market's direction.
Major companies operating in the interventional neurology devices and equipment market include:
• Medtronic plc
• Stryker Corporation
• Terumo Corporation
• Penumbra Inc.
• COVIDien
• Abbott Laboratories
• Merit Medical Systems Inc.
• W. L. Gore & Associates
• Bayer AG
• MicroPort Scientific Corporation
• Boston Scientific Corporation
• Johnson & Johnson
• Medikit Co. Ltd.
• Acandis GmbH
• Biosensors International Ltd.
• Integra LifeSciences Holdings Corporation
• Magstim C-Ltd.
• UreSil LLC
• Cook Group Incorporated
• Siemens Healthineers
• B. Braun Melsungen AG
• Integer Holdings Corporation
• Nihon Kohden Corporation
• LivaNova
• Teleflex Incorporated
• Balt Extrusion SAS
• Rapid Medical Ltd.
• phenox GmbH
• Spiegelberg GmbH & Co. KG
North America was the largest region in the global interventional neurology devices and equipment market in 2023. Asia-Pacific was the second-largest region in the interventional neurology devices and equipment market. The regions covered in the interventional neurology devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.